Literature DB >> 24150229

Postoperative infliximab and elemental diet combination in a case with diffuse, extensive jejunoileal Crohn's disease.

Saori Matsuda1, Takuya Bamba, Shingo Sohma, Takayuki Yamamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24150229     DOI： 10.1007/s00384-013-1777-7

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  4 in total

1.  Long-term outcome of surgical management for diffuse jejunoileal Crohn's disease.

Authors:  T Yamamoto; R N Allan; M R Keighley
Journal:  Surgery       Date:  2001-01       Impact factor: 3.982

2.  Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.

Authors:  Konstantinos Karmiris; Ioannis E Koutroubakis; Costas Xidakis; Maria Polychronaki; Theodora Voudouri; Elias A Kouroumalis
Journal:  Inflamm Bowel Dis       Date:  2006-02       Impact factor: 5.325

3.  Increases in body mass index during infliximab therapy in patients with Crohn's disease: an open label prospective study.

Authors:  Maki Nakahigashi; Takayuki Yamamoto
Journal:  Cytokine       Date:  2011-08-04       Impact factor: 3.861

4.  Impact of infliximab on serum leptin levels in patients with Crohn's disease.

Authors:  Denis Franchimont; Sandrine Roland; Thierry Gustot; Eric Quertinmont; Youssef Toubouti; Marie-Christine Gervy; Jacques Deviere; Andre Van Gossum
Journal:  J Clin Endocrinol Metab       Date:  2005-03-22       Impact factor: 5.958
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.